ID

34192

Description

A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV); ODM derived from: https://clinicaltrials.gov/show/NCT01995071

Lien

https://clinicaltrials.gov/show/NCT01995071

Mots-clés

Versions (1)
  1. 15/01/2019 15/01/2019 -
Détendeur de droits

GSK group of companies

Téléchargé le

15 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Chronic Hepatitis C NCT01995071

Anglais

Eligibility Chronic Hepatitis C NCT01995071

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic hcv infection prior to study enrollment.
Description

ID.1

Type de données

boolean

screening laboratory result indicating hcv genotype 1-infection.
Description

ID.2

Type de données

boolean

subject has plasma hcv rna level greater than 10,000 iu/ml at screening.
Description

ID.3

Type de données

boolean

per local standard, subject is considered to be non-cirrhotic or to have compensated cirrhosis.
Description

ID.4

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of severe, life-threatening or other significant sensitivity to any drug.
Description

ID.5

Type de données

boolean

positive test result for hepatitis b surface antigen (hbsag) or anti-human immunodeficiency virus antibody (hiv ab).
Description

ID.6

Type de données

boolean

prior therapy for the treatment of hcv.
Description

ID.7

Type de données

boolean

any current or past clinical evidence of child pugh b or c classification of clinical history of liver decompensation including ascites (noted on physical exam), variceal bleeding or hepatic encephalopathy.
Description

ID.8

Type de données

boolean

any cause of liver disease other than chronic hcv infection.
Description

ID.9

Type de données

boolean

Retour au début de la page

Similar models

Eligibility Chronic Hepatitis C NCT01995071

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
chronic hcv infection prior to study enrollment.
boolean
ID.2
Item
screening laboratory result indicating hcv genotype 1-infection.
boolean
ID.3
Item
subject has plasma hcv rna level greater than 10,000 iu/ml at screening.
boolean
ID.4
Item
per local standard, subject is considered to be non-cirrhotic or to have compensated cirrhosis.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
history of severe, life-threatening or other significant sensitivity to any drug.
boolean
ID.6
Item
positive test result for hepatitis b surface antigen (hbsag) or anti-human immunodeficiency virus antibody (hiv ab).
boolean
ID.7
Item
prior therapy for the treatment of hcv.
boolean
ID.8
Item
any current or past clinical evidence of child pugh b or c classification of clinical history of liver decompensation including ascites (noted on physical exam), variceal bleeding or hepatic encephalopathy.
boolean
ID.9
Item
any cause of liver disease other than chronic hcv infection.
boolean
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial